Clinical Study to Investigate Safety and Performance of NeuRx DPS in Patients Undergoing Bilateral Lung Transplantation
Prospective, Single-centre, Open-label Clinical Study to Investigate the Safety and Performance of the NeuRx Diaphragm Pacing System (DPS) in Patients Undergoing Bilateral Lung Transplantation
1 other identifier
interventional
4
1 country
1
Brief Summary
This study is a prospective, single-center feasibility study to acquire more knowledge regarding the NeuRx DPS and develop a routine in the optimal pacing of the diaphragm with this system during the weaning period from mechanical ventilation in the Intensive Care Unit in patients after bilateral lung transplant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 2, 2015
CompletedFirst Posted
Study publicly available on registry
April 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedApril 13, 2016
April 1, 2016
1.2 years
April 2, 2015
April 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Safety: Daily assessment of device or procedure-related adverse events until patient discharge.
30 days
Tolerability: Patient withdrawal from treatment.
30 days
Pacing success: Ability to ventilate the patient through diaphragm pacing with or without assistance of mechanical ventilation.
30 days
Secondary Outcomes (1)
Composite endpoint
30 days
Study Arms (1)
NeuRx Diaphragm Pacing System (DPS)®
EXPERIMENTALThe NeuRx Diaphragm Pacing System (DPS)® is placed in the diaphragm during lung transplant.
Interventions
NeuRx Diaphragm Pacing System electrodes are placed in the diaphragm during lung transplant surgery. The diaphragm will be continually paced until the patient is free from the ventilator or the patient is discharged from the ICU whichever. Diaphragm measurements are taken daily to assess tolerability and pacing success.
Eligibility Criteria
You may qualify if:
- Patient is undergoing bilateral lung transplantation
- Signed written informed consent has been obtained prior to any study related procedure
You may not qualify if:
- Diaphragm malformation which makes the electrode insertion impossible
- Presence of contra-indications for magnetical stimulation; pacemaker or implantable cardioverter-defibrillator, prosthetic valve, cervical implants, cervical trauma
- Participation in other clinical studies that could interfere with the results in the ongoing study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Leuven
Leuven, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dries Testelmans, MD
UZ Leuven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2015
First Posted
April 8, 2015
Study Start
February 1, 2015
Primary Completion
April 1, 2016
Study Completion
April 1, 2016
Last Updated
April 13, 2016
Record last verified: 2016-04